Nguyen, Bella
Meehan, Katie
Pereira, Michelle R.
Mirzai, Bob
Lim, Si Hong
Leslie, Connull
Clark, Michael
Sader, Chady
Friedland, Peter
Lindsay, Andrew
Tang, Colin
Millward, Michael
Gray, Elin S.
Lim, Annette M.
Article History
Received: 11 October 2019
Accepted: 4 March 2020
First Online: 8 April 2020
Competing interests
: A.M. Lim - uncompensated advisory board from Merck Sharp & Dohme and Bristol-Myers Squibb with travel and accommodation expenses. The other authors declare that there are no potential conflicts of interest.